Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 10, Pages 1928
Publisher
MDPI AG
Online
2019-05-20
DOI
10.3390/molecules24101928
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin αII b β3 binding in human platelets
- (2018) Chih-Hsuan Hsia et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- JAM-A knockdown accelerates the proliferation and migration of human keratinocytes, and improves wound healing in rats via FAK/Erk signaling
- (2018) Yunchuan Wang et al. Cell Death & Disease
- The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity
- (2018) Valentina Poltavets et al. Frontiers in Oncology
- Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis
- (2017) Yan-Ling Bi et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Role of vinculin in cellular mechanotransduction
- (2016) Wolfgang H. Goldmann CELL BIOLOGY INTERNATIONAL
- FAK and paxillin, two potential targets in pancreatic cancer
- (2016) Rajani Kanteti et al. Oncotarget
- Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway
- (2016) Cheng Peng et al. Scientific Reports
- Garcinol inhibits tumour cell proliferation, angiogenesis, cell cycle progression and induces apoptosis via NF-κB inhibition in oral cancer
- (2015) Sadhna Aggarwal et al. TUMOR BIOLOGY
- Norcantharidin enhances TIMP-2 anti-vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP-2 and MT1-MMP
- (2014) WEI ZHU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma
- (2013) B. D. Crompton et al. CANCER RESEARCH
- Vinculin, cell mechanics and tumour cell invasion
- (2013) Wolfgang H. Goldmann et al. CELL BIOLOGY INTERNATIONAL
- Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
- (2013) Chen-Hsi Hsieh et al. Evidence-based Complementary and Alternative Medicine
- Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
- (2012) Chao-Bin Yeh et al. PLoS One
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Natural Products as Anti-Invasive and Anti-Metastatic Agents
- (2011) Y.-L. Jiang et al. CURRENT MEDICINAL CHEMISTRY
- Norcantharidin, a protective therapeutic agent in renal tubulointerstitial fibrosis
- (2011) Ying Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Drug Development for Cancer Chemoprevention: Focus on Molecular Targets
- (2010) Karen A. Johnson et al. SEMINARS IN ONCOLOGY
- The Use of Animal Models for Cancer Chemoprevention Drug Development
- (2010) Vernon E. Steele et al. SEMINARS IN ONCOLOGY
- A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells
- (2009) Yu-Jen Chen et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action
- (2009) Yan Huang et al. CYTOTECHNOLOGY
- Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model
- (2009) J. K. Slack-Davis et al. MOLECULAR CANCER THERAPEUTICS
- Natural compounds for cancer treatment and prevention
- (2009) Stefania Nobili et al. PHARMACOLOGICAL RESEARCH
- Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
- (2008) W. G. Roberts et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search